These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9236508)

  • 21. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
    Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
    Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasomes are involved in the constitutive degradation of growth hormone receptors.
    Takagi K; Saito Y; Sawada JI
    Biol Pharm Bull; 2001 Jul; 24(7):744-8. PubMed ID: 11456111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.
    Kaulsay KK; Zhu T; Bennett W; Lee KO; Lobie PE
    Endocrinology; 2001 Feb; 142(2):767-77. PubMed ID: 11159849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and purification of a deleted human growth hormone, hGH delta 135-146: sensitivity to plasmin cleavage and in vitro and in vivo bioactivities.
    Alam KS; Fujikawa T; Yoshizato H; Tanaka M; Nakashima K
    J Biotechnol; 2000 Feb; 78(1):49-59. PubMed ID: 10702910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor.
    Frank SJ; Gilliland G; Van Epps C
    Endocrinology; 1994 Jul; 135(1):148-56. PubMed ID: 8013347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of FLT3 ligand on human leukemia cells. I. Proliferative response of myeloid leukemia cells.
    Dehmel U; Zaborski M; Meierhoff G; Rosnet O; Birnbaum D; Ludwig WD; Quentmeier H; Drexler HG
    Leukemia; 1996 Feb; 10(2):261-70. PubMed ID: 8637235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts.
    Estrov Z; Meir R; Barak Y; Zaizov R; Zadik Z
    J Clin Oncol; 1991 Mar; 9(3):394-9. PubMed ID: 1999709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
    Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
    Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone.
    Bidlingmaier M; Strasburger CJ
    Handb Exp Pharmacol; 2010; (195):187-200. PubMed ID: 20020365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone receptor gene expression on human lymphocytic and monocytic cell lines.
    Derfalvi B; Szalai C; Mandi Y; Kiraly A; Falus A
    Cell Biol Int; 1998 Nov; 22(11-12):849-53. PubMed ID: 10873296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of growth hormone receptors by lymphocyte subpopulations in the human tonsil.
    Thellin O; Coumans B; Zorzi W; Barnard R; Hennen G; Heinen E; Igout A
    Dev Immunol; 1998; 6(3-4):295-304. PubMed ID: 9814603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel peptide antagonist of the human growth hormone receptor.
    Basu R; Nahar K; Kulkarni P; Kerekes O; Sattler M; Hall Z; Neggers S; Holub JM; Kopchick JJ
    J Biol Chem; 2021; 296():100588. PubMed ID: 33774052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DeltahGHR, a novel biosafe cell surface-labeling molecule for analysis and selection of genetically transduced human cells.
    García-Ortiz MJ; Serrano F; Abad JL; González MA; Kremer L; Mellado M; Rodríguez-Frade JM; Martínez-A C; Bernad A
    Hum Gene Ther; 2000 Jan; 11(2):333-46. PubMed ID: 10680846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single arginine residue determines species specificity of the human growth hormone receptor.
    Souza SC; Frick GP; Wang X; Kopchick JJ; Lobo RB; Goodman HM
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):959-63. PubMed ID: 7862673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase.
    Frank SJ; Gilliland G; Kraft AS; Arnold CS
    Endocrinology; 1994 Nov; 135(5):2228-39. PubMed ID: 7956946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.
    Untergasser G; Rumpold H; Hermann M; Dirnhofer S; Jilg G; Berger P
    Exp Gerontol; 1999 Apr; 34(2):275-87. PubMed ID: 10363793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective modification at the N-terminal region of human growth hormone that shows antagonistic activity.
    Tchelet A; Vogel T; Helman D; Guy R; Neospouolus C; Goffin V; Djiane J; Gertler A
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):141-52. PubMed ID: 9220030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.